In 2012, the U.S. Congress directed the GAO to study drug shortages through the Food and Drug Administration Safety and Innovation Act.
The report also recognized the FDA has improved its response to drug shortages and has effectively worked to prevent more potential shortages, however, “challenges remain.”
The ASA is reviewing the report and its recommendations.
More Articles on Anesthesia:
3 ASA Anesthesiologists to Travel to Rwanda for Teaching Program
PhyMed Names Michael Morgan COO of Anesthesia Medical Group
Dr. Brian Jones Joins Providence Pain Management Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.